Latest Breaking News On - Biopsy market report - Page 1 : comparemela.com

Product News: Sysmex has launched Plasma-SeqSensei liquid biopsy RUO kits in EMEA 01 Apr 2021 Sysmex Europe GmbH, together with Sysmex Inostics GmbH, has announced that they will launch the Plasma-SeqSensei™ liquid biopsy research use only (RUO) kits for colorectal cancer (CRC), non-small cell lung cancer (NSCLC), melanoma and thyroid cancer.  Liquid biopsy detects material in body fluids to assess the extent of disease, most often used for the detection of cancerous material in plasma. Though several molecular techniques are used, next generation sequencing is considered to be the most important method to detect minute amounts of circulating tumour DNA (ctDNA). In contrast to tissue biopsy, which is not always obtainable and much more invasive, liquid biopsy is well-suited for clinical research purposes due to its less invasive nature, high concordance to tissue samples in many cancers and real time information available.

Sysmex inostics gmbBert vogelsteinKennethw kinzlerIsaac kindeNick papadopoulosSysmex europe gmbKlaus alix panabiJohns hopkins universityProduct newsEurope gmbhSysmex inostics gmbhCell perspective liquid biopsiesWhat we do not knowReviews clinical oncologyClinical oncologyBio consulting